This is a StreetInsider.com Premium Only Page

Affimed (AFMD) – Hot FDA News

Dec 12, 2022 07:26 AM Affimed (AFMD) Reports Topline Data from AFM13 Monotherapy Phase 2 REDIRECT Study in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

Apr 11, 2022 06:42 AM Affimed (AFMD) Gains Following Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells

Nov 22, 2021 07:12 AM

Apr 9, 2021 06:56 AM

Oct 8, 2018 04:16 PM

Aug 27, 2018 04:13 PM

Dec 11, 2017 06:02 AM

Jun 27, 2017 05:41 AM

Jun 6, 2017 06:14 AM

Jan 25, 2016 08:21 AM